Compumedics has locked in a pivotal five-year contract with Philips Australia, cementing Somfit as the leading device for pharmacy-based sleep testing and underpinning significant SaaS revenue growth through 2028.
Victor Sage
22 Jan 2025
Subscribe to Updates
Get moves for Compumedics (ASX:CMP) direct to your inbox.
You're on the list!
We'll ping you the moment Compumedics (ASX:CMP) makes a move.
Until then, follow us on socials.
Join 1000's of market focused, signal seeking investors. Unsubscribe anytime. We don't sell your data.